Skip to main content

MAX IV: Rapid Access Call for Proposals: SARS-CoV-2 and urgent (e.g. health-related) research


Published Jun 22, 2020

In order to support science towards understanding the SARS-CoV-2 virus, MAX IV would like to offer its instrumentation and beamtime – on a short notice base – to facilitate efforts to discover more about the virus and bring us closer to an effective vaccine, diagnostics or treatment.

Therefore, we are offering rapid access for groups who require instrument time for projects directly related to SARS-CoV-2 viral proteins such as COVID-19 related enzyme targets, membrane receptor complexes, antibody complexes etc. (i.e. non-infectious samples).

Based on the number and nature of requests for rapid access, MAX IV will select on scientific excellence.

In addition, in light of facility closures worldwide, we may, on availability and best effort base, offer some MX beamtime at BioMAX for urgent, e.g. health-related, research through remote operation or mail-in (in cooperation).

In order to submit a proposal for rapid access under these conditions please email  with a one-paragraph abstract describing your research for eligibility and to receive further instructions.

More information (maxiv).

Did you find this page useful?
Thank you for helping us!
Belongs to: KTH Intranet
Last changed: Jun 22, 2020